Barry D. Quart, President and CEO at Ardea Biosciences, Inc./DE (RDEA), sold 25,000 shares at $14.57 ($364K) on 2010-02-08, disclosed to the SEC on 2010-02-10.
Scheduled sale ($364k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| KNSA | SELL | 2026-02-12 | $126K | — | Filing → |
| KNSA | SELL | 2026-02-04 | $722K | — | Filing → |
| KNSA | SELL | 2025-12-17 | $1.7M | — | Filing → |